Progyny Stock Analysis

PGNY Stock  USD 21.71  0.50  2.36%   
Progyny is fairly valued with Real Value of 21.28 and Target Price of 18.86. The main objective of Progyny stock analysis is to determine its intrinsic value, which is an estimate of what Progyny is worth, separate from its market price. There are two main types of Progyny's stock analysis: fundamental analysis and technical analysis.
The Progyny stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Progyny is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Progyny Stock trading window is adjusted to America/New York timezone.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.

Progyny Stock Analysis Notes

About 93.0% of the company shares are owned by institutional investors. The book value of Progyny was at this time reported as 4.98. The company had not issued any dividends in recent years. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Progyny operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 311 people. To find out more about Progyny contact Peter Anevski at 212 888 3124 or learn more at https://www.progyny.com.

Progyny Quarterly Total Revenue

298.43 Million

Progyny Investment Alerts

Progyny is unlikely to experience financial distress in the next 2 years
Over 93.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Q4 Earnings Outperformers Clover Health And The Rest Of The Health Insurance Providers Stocks

Progyny Upcoming and Recent Events

Earnings reports are used by Progyny to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
26th of February 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Progyny Largest EPS Surprises

Earnings surprises can significantly impact Progyny's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-08-05
2020-06-30-0.03-0.020.0133 
2020-03-05
2019-12-310.020.01-0.0150 
2019-12-04
2019-09-300.020.030.0150 
View All Earnings Estimates

Progyny Environmental, Social, and Governance (ESG) Scores

Progyny's ESG score is a quantitative measure that evaluates Progyny's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Progyny's operations that may have significant financial implications and affect Progyny's stock price as well as guide investors towards more socially responsible investments.

Progyny Thematic Classifications

In addition to having Progyny stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Healthcare Idea
Healthcare
USA Equities from Healthcare industry as classified by Fama & French

Progyny Stock Institutional Investors

Shares
Invenomic Capital Management, Lp2024-12-31
1.6 M
River Road Asset Management, Llc2024-12-31
1.5 M
Fort Washington Investment Advisors Inc2024-12-31
1.5 M
Barclays Plc2024-12-31
1.4 M
Baillie Gifford & Co Limited.2024-12-31
1.3 M
Voloridge Investment Management, Llc2024-12-31
1.2 M
Dimensional Fund Advisors, Inc.2024-12-31
1.2 M
Millennium Management Llc2024-12-31
1.1 M
Bank Of America Corp2024-12-31
952.8 K
Blackrock Inc2024-12-31
14 M
Vanguard Group Inc2024-12-31
8.7 M
Note, although Progyny's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Progyny Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.81 B.

Progyny Profitablity

The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.09  0.10 
Return On Capital Employed 0.15  0.16 
Return On Assets 0.09  0.09 
Return On Equity 0.13  0.14 

Management Efficiency

Progyny has return on total asset (ROA) of 0.0618 % which means that it generated a profit of $0.0618 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1114 %, meaning that it created $0.1114 on every $100 dollars invested by stockholders. Progyny's management efficiency ratios could be used to measure how well Progyny manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.1 in 2025. Return On Capital Employed is likely to rise to 0.16 in 2025. At this time, Progyny's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 98.9 M in 2025, whereas Total Assets are likely to drop slightly above 377.5 M in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 4.61  4.84 
Tangible Book Value Per Share 4.43  4.65 
Enterprise Value Over EBITDA 21.27  22.34 
Price Book Value Ratio 3.74  3.55 
Enterprise Value Multiple 21.27  22.34 
Price Fair Value 3.74  3.55 
Enterprise Value1.4 BB
Leadership effectiveness at Progyny is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin
0.0529
Profit Margin
0.0466
Beta
1.417
Return On Assets
0.0618
Return On Equity
0.1114

Technical Drivers

As of the 19th of March, Progyny holds the Coefficient Of Variation of 590.43, semi deviation of 1.67, and Risk Adjusted Performance of 0.1561. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Progyny, as well as the relationship between them.

Progyny Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Progyny middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Progyny. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Progyny Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Progyny insiders, such as employees or executives, is commonly permitted as long as it does not rely on Progyny's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Progyny insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Progyny Outstanding Bonds

Progyny issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Progyny uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Progyny bonds can be classified according to their maturity, which is the date when Progyny has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Progyny Predictive Daily Indicators

Progyny intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Progyny stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Progyny Corporate Filings

F4
5th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
3rd of March 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
8K
28th of February 2025
An amendment to a previously filed Form 8-K
ViewVerify
8K
27th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F3
21st of January 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
16th of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
13th of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
6th of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Progyny Forecast Models

Progyny's time-series forecasting models are one of many Progyny's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Progyny's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Progyny Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Progyny prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Progyny shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Progyny. By using and applying Progyny Stock analysis, traders can create a robust methodology for identifying Progyny entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.07  0.07 
Operating Profit Margin 0.06  0.06 
Net Profit Margin 0.05  0.05 
Gross Profit Margin 0.22  0.16 

Current Progyny Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Progyny analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Progyny analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
18.86Buy10Odds
Progyny current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Progyny analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Progyny stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Progyny, talking to its executives and customers, or listening to Progyny conference calls.
Progyny Analyst Advice Details

Progyny Stock Analysis Indicators

Progyny stock analysis indicators help investors evaluate how Progyny stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Progyny shares will generate the highest return on investment. By understating and applying Progyny stock analysis, traders can identify Progyny position entry and exit signals to maximize returns.
Begin Period Cash Flow97.3 M
Common Stock Shares Outstanding95.4 M
Total Stockholder Equity422.1 M
Tax Provision28.9 M
Quarterly Earnings Growth Y O Y-0.17
Property Plant And Equipment Net29.6 M
Cash And Short Term Investments228 M
Cash162.3 M
Accounts Payable95.1 M
Net Debt-143 M
50 Day M A21.5452
Total Current Liabilities168.6 M
Other Operating Expenses1.1 B
Non Current Assets Total134.4 M
Forward Price Earnings13.587
Non Currrent Assets OtherM
Stock Based Compensation128.1 M

Additional Tools for Progyny Stock Analysis

When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.